Form 4 Filing for Townsend Richard Nolan

Townsend Richard Nolan, Chief Executive Officer of Lexeo Therapeutics, Inc. (LXEO), reported the sale of 55,000 shares of Common Stock on April 6, 2026. The weighted average sale price was $5.6934 per share, with prices ranging from $5.56 to $5.94. This transaction was conducted under a Rule 10b5-1 trading plan. Following the sale, Mr. Nolan owns 340,106 shares, which includes 261,349 Restricted Stock Units (RSUs).